Future research could include biochemical analyses of cyst fluid to characterize its composition and crystal-forming potential, in vitro studies exploring the physicochemical conditions that promote urate crystal formation within mucopolysaccharide-rich environments, and clinical investigations evaluating whether aromatase inhibitor therapy, such as exemestane, influences local tissue metabolism or predisposes to crystal deposition. The gene discussed is CYP19A1; the disease is cyst.